首页> 外文期刊>Pharmaceutical Methods >Continuous Flow Hydride Generation-Fourier Transforms Infrared Spectrometric Determination of Antimony in Homeopathic (Antihomotoxic) Products
【24h】

Continuous Flow Hydride Generation-Fourier Transforms Infrared Spectrometric Determination of Antimony in Homeopathic (Antihomotoxic) Products

机译:连续流动氢化物发生-傅立叶变换红外光谱法测定顺势疗法(抗同毒)产品中的锑

获取原文
           

摘要

Introduction: Antimony potassium tartrate is a component of certain expectorants in homeopathic medicine, particularly in those classified as antihomotoxic remedies. Given that antihomotoxic products are prepared with different epistemological and methodological statuses, they should be tested to prevent eventual toxic effects. Methods: In this study, we evaluate the possibility of using continuous flow hydride generation (HG) coupled with Fourier transforms infrared spectroscopy (FTIR) for determining antimony concentration in antihomotoxic products containing antimony potassium tartrate. Results: The results showed good agreement with the theoretically estimated values for the liquid commercial samples, in the range from 0.5 μg/mL to 30 μg/mL, following the principle of decimal dilutions used in homeopathic medicine. Liquid samples were analyzed directly from the commercial container. Discussion: In the absence of regulatory standards for antihomotoxic products, the proposed HG-FTIR method in gaseous phase provides an acceptable analytical capability for homeopathical compendiums, not only for analyzing raw materials and mother tinctures but also for determining identity and uniformity content of finished products which should comply with pharmacopoeial specifications, and also in the determination of toxic content, 6 μg antimony per kg body weight, tolerable daily intake (TDI) proposed by the World Health Organization.
机译:简介:酒石酸锑钾是顺势疗法药物中某些祛痰药的成分,尤其是归类为抗同毒药的那些。鉴于制备的抗同毒产品具有不同的认识论和方法论状态,应对其进行测试以防止最终的毒性作用。方法:在这项研究中,我们评估了使用连续流动氢化物生成(HG)结合傅里叶变换红外光谱(FTIR)来确定含酒石酸锑钾的抗同毒产品中锑浓度的可能性。结果:根据顺势疗法药物中使用的十进制稀释原理,结果与液体商业样品的理论估计值在0.5μg/ mL至30μg/ mL的范围内具有很好的一致性。直接从商用容器中分析液体样品。讨论:在缺乏抗同毒产品的监管标准的情况下,拟议的气相HG-FTIR方法为顺势药典提供了可接受的分析能力,不仅用于分析原料和母but,而且还用于确定成品的身份和均匀度其应符合药典规范,并且在确定毒性含量时应采用世界卫生组织建议的每千克体重6μg锑和可耐受的每日摄入量(TDI)。

著录项

  • 来源
    《Pharmaceutical Methods》 |2017年第1期|共10页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号